Europe's last penicillin plant faces closure amid competition from China
The possible end of Europe's last penicillin factory would reduce regional antibiotic manufacturing capacity and tighten supply of penicillin drugs.
Source →The trace
How it reaches your house.
Starting from Penicillin G (Pen G), we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Penicillin G (Pen G) →Shortage riskPenicillin G is a critical input to antibiotics, so a supply halt directly tightens antibiotic output.
96% confidencePenicillin G (Pen G) →Shortage riskAustria/EU is the regional source of the last integrated European penicillin plant, so closure removes that local supply share.
90% confidenceCentrient Pharmaceuticals B.V. →Shortage risk6-Aminopenicillanic Acid (6-APA)
If Centrient halts production, this edge implies an 18% share of 6-APA supply is lost, and the 18-month replacement lag makes the shortage material.
Hop 2
6-Aminopenicillanic Acid (6-APA) →Shortage risk6-APA is a critical upstream input for antibiotics, so a production halt in the penicillin chain directly constrains antibiotic output and tightens supply.
96% confidence7-Aminocephalosporanic Acid (7-ACA) →Shortage risk7-ACA is a critical input to antibiotics, so a production halt at this node would directly tighten antibiotic supply.
95% confidenceAntibiotics →Prices ease6-Aminopenicillanic Acid (6-APA)
Semisynthetic antibiotic production depends heavily on 6-APA, so a penicillin plant closure reduces demand and puts this critical intermediate under price pressure.
Hop 3
Injectable Hospital Antibiotics (Vancomycin, Pip-Tazo, Cefepime) →Shortage riskThis is a critical, high-dependency supply link, so tightness in injectable hospital antibiotics can propagate as a shortage to the broader antibiotics category.
71% confidence
Where it lands
What you buy, and what you own.
Goods you buy
Antibiotics
Companies you may own
CSPC Pharmaceutical Group LimitedCentrient Pharmaceuticals B.V.
Tap a company to see what it told the SEC could break it.
In the MyPRIA app, this is checked against your own holdings.